Category: Nutrition & Supplements
-
GLP-1 microdosing promises longevity and lower inflammation. No completed trial has tested it, and every dose curve in the real trials runs the other way.
-
The FDA peptides 2026 vote changed no law: no peptide is on the compounding list, FDA’s reviewers proposed keeping them off, and the vote is not binding.
-
A VITAL sub-study found vitamin D slowed telomere loss by 140 base pairs in 4 years. The honest read on vitamin D telomeres, and why the marketing overshoots.
-
A C15:0 supplement rests on one small trial: 30 young adults, 12 weeks, no weight change. Here is what the fatty15 evidence shows and what food gives you.
-
NAD IV therapy costs $200 to $1,000 a session. A 2026 review of 113 studies found zero trials of the drip itself. Here is what the evidence really shows.
-
An audit ran the same 16 epigenetic clocks across 51 human trials. Only 19 interventions did anything to slow biological aging, and few were supplements.
-
The biggest trial of testosterone therapy risks found no extra heart attacks, but more irregular heartbeats, lung clots and broken bones. The full picture.
-
The mouthwash blood pressure link is real but small: antiseptic rinsing stalls a nitric oxide pathway on your tongue. Here is what the trials actually show.
-
Adrenal fatigue is not a real diagnosis: a review of 58 studies found the cortisol tests disagreed. Here is what the tiredness usually turns out to be.
-
The best melatonin dosage is smaller than the bottle suggests: benefit flattens near 4 mg, and taking it 2 to 3 hours before bed matters more than milligrams.
Bio-Hacking.Blog 